Doxaminol

This classification denotes a beta-adrenergic agonist with the molecular formula C26H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1RZ4ML637I, chemically known as 6,11-dihydro-n-(2-hydroxy-3-phenoxypropyl)-n-methyldibenz(b,e)oxepin-11-ethylamine but generally known as doxaminol, which bears US NIH Compound Identifier 68721. European Medicines Agency schedules Doxaminol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06381MIG. The term DOXAMINOL is an International Non-Proprietary Name. DOXAMINOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule doxaminol under HS 29329985 and SITC 51569. As of Q4 2014, DOXAMINOL remains the US FDA Preferred Term for this commodity. Doxaminol bears US NLM identifiers UMLS ID C0058717 and NCI Concept Code C65473. SMILES: O1C2C(C(CCN(CC(O)COC3CCCCC3)C)C3C(C1)CCCC3)CCCC2.